intercure (dba canndoc) (nasdaq: incr) (tsx: incr.u) (tase: incr) is the leading, profitable, and fastest growing cannabis company outside of north america. canndoc, a wholly owned subsidiary of intercure, is israel’s largest licensed cannabis producer and one of the first to offer good manufacturing practices (gmp) certified and pharmaceutical-grade medical cannabis products. intercure leverages its market leading distribution network, best in class international partnerships and a high-margin vertically integrated "seed-to-sale" model to lead the fastest growing cannabis global market outside of north america. for more information, visit: http://www.intercure.co.
Company profile
Ticker
INCR
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
INCR stock data
Latest filings (excl ownership)
6-K
InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBIDTA of over NIS 50 million
1 Apr 24
6-K
InterCure Provides an Update Regarding Nir Oz Facility
13 Feb 24
6-K
Current report (foreign)
13 Feb 24
6-K
InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain
31 Jan 24
6-K
Current report (foreign)
14 Dec 23
6-K
Annual General Meeting of Shareholders to Be
8 Nov 23
6-K
Current report (foreign)
31 Oct 23
6-K
InterCure Provides an Update Regarding the Security Situation in Israel
17 Oct 23
6-K
InterCure Announces Record Revenues First Half of 2023 with over 14% growth YOY
31 Aug 23
6-K
Current report (foreign)
14 Aug 23
Latest ownership filings
Financial summary
Quarter (USD) | Dec 22 | Dec 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Institutional ownership, Q3 2023
7.6% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 19 |
Opened positions | 3 |
Closed positions | 2 |
Increased positions | 6 |
Reduced positions | 5 |
13F shares | Current |
---|---|
Total value | 5.33 bn |
Total shares | 3.41 mm |
Total puts | 2.10 k |
Total calls | 25.20 k |
Total put/call ratio | 0.1 |
Largest owners | Shares | Value |
---|---|---|
Ibex Investors | 1.91 mm | $2.99 bn |
Mirae Asset Global Investments | 869.90 k | $1.37 bn |
AdvisorShares Investments | 231.05 k | $365.05 mm |
Healthcare Of Ontario Pension Plan Trust Fund | 212.50 k | $325.13 mm |
Cambria Investment Management | 58.00 k | $91.63 mm |
Citadel Advisors | 52.54 k | $83.02 mm |
BLK Blackrock | 24.16 k | $37.93 mm |
Renaissance Technologies | 18.80 k | $30.00 k |
Susquehanna International | 14.66 k | $23.16 mm |
Geode Capital Management | 14.15 k | $22.35 mm |
Press releases
InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million
1 Apr 24
Thinking about buying stock in Braze, Velo3D, InterCure, Equillium, or Bioatla?
28 Mar 24
InterCure Congratulates Germany on Cannabis Reform, Expanding its Global Footprint
22 Mar 24
InterCure Provides an Update Regarding Nir Oz Facility
13 Feb 24
InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain
31 Jan 24